Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability and Proliferation Assay Using WST-8

Executive Summary: The Cell Counting Kit-8 (CCK-8) is a colorimetric assay that quantifies cell viability and proliferation by detecting mitochondrial dehydrogenase activity using WST-8, a water-soluble tetrazolium salt. Each CCK-8 assay correlates the amount of formazan dye produced to the number of viable cells, with readouts possible in as little as 1–4 hours (Mao et al., 2025). The assay is non-radioactive, does not require solubilization steps, and is more sensitive than MTT or XTT. CCK-8 is widely used in cancer, neurodegenerative, and metabolic disease research to assess cytotoxicity and proliferation in vitro (Product page). Limitations include interference by reducing agents and incompatibility with certain colored compounds.

Biological Rationale

Assessing cell viability and proliferation is foundational in biomedical research. Cell health is commonly measured by mitochondrial activity, as viable cells maintain active dehydrogenases that reduce tetrazolium salts to colored formazan products. Traditional tetrazolium-based assays (e.g., MTT, XTT, WST-1) have limitations related to solubility and sensitivity. The Cell Counting Kit-8 (CCK-8) uses WST-8, a water-soluble tetrazolium salt, improving assay clarity and ease of quantification (Cell Counting Kit-8 (CCK-8)). This method enables high-throughput, non-destructive analysis of live cells, which is essential for drug screening, toxicity, and proliferation studies. In disease models ranging from influenza-induced inflammation to cancer, rapid and reliable cell viability assessment is critical for interpreting cellular responses to interventions (Mao et al., 2025).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8's core chemical is WST-8, a water-soluble tetrazolium salt. In metabolically active, living cells, mitochondrial dehydrogenases catalyze the bioreduction of WST-8 to produce a soluble orange formazan dye. The reaction requires NADH or NADPH as electron donors, which are generated during cellular respiration. The intensity of the formazan color, measured at 450 nm by a microplate reader, is directly proportional to the number of viable cells present in the well (product documentation).

Unlike MTT, where formazan is insoluble and requires a dissolution step, the CCK-8 assay's product is water-soluble. This enables a single-step, homogeneous assay without additional washing or solubilization. The assay is non-radioactive and non-toxic, allowing for downstream analysis of the same cells. The reaction occurs at standard culture conditions (37°C, 5% CO₂) and is typically complete within 1–4 hours, depending on cell type and density.

Evidence & Benchmarks

• CCK-8 demonstrates higher sensitivity and a broader dynamic range than MTT, XTT, and WST-1 assays, enabling accurate detection in low cell number conditions (Mao et al., 2025).
• In mouse models of influenza pneumonia, CCK-8 was used to quantify macrophage viability post-treatment, confirming reproducible results with minimal background (Mao et al., 2025).
• CCK-8 is compatible with high-throughput screening (HTS) formats and automation, supporting 96- and 384-well microplate layouts (product page).
• The water-soluble formazan product allows direct absorbance measurement and rapid data acquisition without additional reagents or steps (cell counting kit 8 applications).
• CCK-8 has been validated in studies involving cancer cells, neural stem cells, and primary immune cells, supporting its use in diverse research models (Mao et al., 2025).

Compared to mechanistic insights into CCK-8, this article provides updated quantitative benchmarks and direct application notes from peer-reviewed influenza and immune cell research.

Applications, Limits & Misconceptions

CCK-8 is widely used for:

• Quantifying cell proliferation in cancer, neurodegenerative, and metabolic disease research.
• Assessing cytotoxicity of drugs, toxins, or experimental treatments.
• Measuring cellular metabolic activity as a proxy for viability.
• Screening compounds in high-throughput pharmacological studies.
• Evaluating immune cell activation and survival post-treatment.

In contrast to the neuroinflammatory CCK-8 review, this article highlights applications in infectious disease and cross-validates performance in non-neural cell lines.

Common Pitfalls or Misconceptions

• CCK-8 does not distinguish between apoptosis and necrosis; it measures overall metabolic activity.
• Strong reducing agents (e.g., ascorbate, DTT) or colored compounds in culture can interfere with absorbance readings.
• CCK-8 is not suitable for non-adherent cells in suspension without prior optimization for cell settling.
• High cell density (>1x10⁵ cells/well) may saturate the signal and reduce assay linearity.
• CCK-8 should not be used for kinetic monitoring of rapid cell death (<1 hour) due to the time required for formazan accumulation.

Workflow Integration & Parameters

To perform a CCK-8 assay:

1. Seed cells in a 96- or 384-well plate at the desired density (typically 1,000–10,000 cells/well for adherent cells).
2. Allow cells to attach and recover overnight at 37°C, 5% CO₂.
3. Add 10 μL of CCK-8 reagent per 100 μL medium (1:10 dilution, as per K1018 kit instructions).
4. Incubate for 1–4 hours, shielded from direct light; optimal time varies by cell type and density.
5. Measure absorbance at 450 nm using a microplate reader. Reference wavelength (650 nm) is optional for background correction.

Data are reported as absorbance units (AU), and cell numbers are calculated using a standard curve if absolute quantification is needed. The CCK-8 method is compatible with additional downstream assays (e.g., RNA/protein extraction) due to its low toxicity.

This article extends the integration details presented in translational research overviews by providing explicit reagent-to-volume ratios and highlighting compatibility with high-throughput automation.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) is a robust, sensitive, and convenient solution for in vitro cell viability and proliferation analysis. Its WST-8-based chemistry delivers higher sensitivity and fewer technical steps than older tetrazolium assays. The K1018 kit is validated in infectious disease, cancer, and metabolic research models, supporting its use in both academic and industry settings (see product page). As cell-based screening and translational research expand, CCK-8's compatibility with automation and downstream analytics positions it as a core tool for quantitative cellular assays. Future developments may further increase sensitivity and expand the dynamic range to support emerging single-cell and 3D culture models.